HLS Therapeutics Inc. (HLS.TO)
CAD 4.24
(-0.7%)
CAD 4.24
(-0.7%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.85 USD | -16.44% |
| 2022 | -0.73 USD | -78.05% |
| 2021 | -0.41 USD | 14.58% |
| 2020 | -0.48 USD | 28.36% |
| 2019 | -0.67 USD | 27.17% |
| 2018 | -0.92 USD | -283.33% |
| 2017 | -0.24 USD | -579.89% |
| 2016 | -0.04 USD | 63.94% |
| 2015 | -0.10 USD | -115.06% |
| 2014 | 0.65 USD | 32.65% |
| 2013 | 0.49 USD | -40.96% |
| 2012 | 0.83 USD | 38.33% |
| 2011 | 0.60 USD | 1980.88% |
| 2010 | -0.03 USD | -129.0% |
| 2009 | 0.11 USD | 150.0% |
| 2008 | -0.22 USD | -166.67% |
| 2007 | 0.33 USD | 449.08% |
| 2006 | 0.06 USD | -86.93% |
| 2005 | 0.46 USD | 200.0% |
| 2004 | -0.46 USD | -406.67% |
| 2003 | 0.15 USD | 15.38% |
| 2002 | 0.13 USD | -27.78% |
| 2001 | 0.18 USD | -14.29% |
| 2000 | 0.21 USD | -46.15% |
| 1999 | 0.39 USD | 156.52% |
| 1998 | -0.69 USD | -400.0% |
| 1997 | 0.23 USD | -77.67% |
| 1996 | 1.03 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.18 USD | 5.26% |
| 2024 Q1 | -0.19 USD | -11.76% |
| 2023 FY | - USD | -16.44% |
| 2023 Q1 | -0.18 USD | 10.0% |
| 2023 Q2 | -0.29 USD | -61.11% |
| 2023 Q3 | -0.21 USD | 27.59% |
| 2023 Q4 | -0.17 USD | 19.05% |
| 2022 Q1 | -0.11 USD | 15.38% |
| 2022 FY | - USD | -78.05% |
| 2022 Q3 | -0.14 USD | 50.0% |
| 2022 Q2 | -0.28 USD | -154.55% |
| 2022 Q4 | -0.20 USD | -42.86% |
| 2021 Q3 | -0.06 USD | 12.57% |
| 2021 Q1 | -0.15 USD | 34.78% |
| 2021 FY | - USD | 14.58% |
| 2021 Q2 | -0.07 USD | 53.33% |
| 2021 Q4 | -0.13 USD | -112.42% |
| 2020 Q3 | -0.05 USD | 72.7% |
| 2020 Q4 | -0.23 USD | -321.25% |
| 2020 Q2 | -0.20 USD | -4181.63% |
| 2020 FY | - USD | 28.36% |
| 2020 Q1 | 0.00 USD | 101.26% |
| 2019 Q1 | -0.14 USD | -1100.0% |
| 2019 Q2 | -0.06 USD | 57.14% |
| 2019 FY | - USD | 27.17% |
| 2019 Q4 | -0.39 USD | -500.0% |
| 2019 Q3 | -0.06 USD | -8.33% |
| 2018 Q2 | -0.02 USD | 89.21% |
| 2018 FY | - USD | -283.33% |
| 2018 Q4 | 0.01 USD | 101.94% |
| 2018 Q3 | -0.72 USD | -3412.2% |
| 2018 Q1 | -0.19 USD | 9.52% |
| 2017 Q1 | -0.01 USD | 53.1% |
| 2017 FY | - USD | -579.89% |
| 2017 Q4 | -0.21 USD | -1566.67% |
| 2017 Q3 | -0.01 USD | -23.53% |
| 2017 Q2 | -0.01 USD | 3.77% |
| 2016 Q3 | -0.01 USD | 57.39% |
| 2016 FY | - USD | 63.94% |
| 2016 Q2 | -0.02 USD | 9.28% |
| 2016 Q1 | -0.02 USD | -25.97% |
| 2016 Q4 | -0.02 USD | -201.33% |
| 2015 Q2 | -0.00 USD | 95.22% |
| 2015 Q3 | -0.01 USD | -315.62% |
| 2015 Q4 | -0.02 USD | -15.79% |
| 2015 FY | - USD | -115.06% |
| 2015 Q1 | -0.07 USD | -124.78% |
| 2014 FY | - USD | 32.65% |
| 2014 Q4 | 0.27 USD | 58.82% |
| 2014 Q1 | 0.14 USD | -12.5% |
| 2014 Q2 | 0.08 USD | -46.43% |
| 2014 Q3 | 0.17 USD | 126.67% |
| 2013 Q3 | 0.12 USD | 215.79% |
| 2013 Q1 | 0.18 USD | -18.18% |
| 2013 FY | - USD | -40.96% |
| 2013 Q4 | 0.16 USD | 33.33% |
| 2013 Q2 | 0.04 USD | -78.89% |
| 2012 Q4 | 0.22 USD | 4.76% |
| 2012 FY | - USD | 38.33% |
| 2012 Q3 | 0.21 USD | -4.55% |
| 2012 Q2 | 0.22 USD | 22.22% |
| 2012 Q1 | 0.18 USD | -5.26% |
| 2011 Q1 | 0.19 USD | 46.15% |
| 2011 Q2 | 0.13 USD | -31.58% |
| 2011 Q3 | 0.12 USD | -7.69% |
| 2011 Q4 | 0.19 USD | 58.33% |
| 2011 FY | - USD | 1980.88% |
| 2010 Q2 | -0.09 USD | -1012.82% |
| 2010 FY | - USD | -129.0% |
| 2010 Q1 | -0.01 USD | -109.63% |
| 2010 Q4 | 0.13 USD | 400.23% |
| 2010 Q3 | -0.04 USD | 50.12% |
| 2009 Q3 | -0.04 USD | -145.76% |
| 2009 Q2 | 0.09 USD | 384.16% |
| 2009 FY | - USD | 150.0% |
| 2009 Q4 | 0.08 USD | 305.58% |
| 2009 Q1 | -0.03 USD | 91.09% |
| 2008 FY | - USD | -166.67% |
| 2008 Q4 | -0.34 USD | -549.74% |
| 2008 Q3 | 0.08 USD | 92.37% |
| 2008 Q2 | 0.04 USD | 35.05% |
| 2008 Q1 | 0.03 USD | -67.67% |
| 2007 Q1 | 0.06 USD | 1497.37% |
| 2007 FY | - USD | 449.08% |
| 2007 Q4 | 0.09 USD | 27.66% |
| 2007 Q3 | 0.07 USD | -24.92% |
| 2007 Q2 | 0.09 USD | 54.7% |
| 2006 Q1 | 0.03 USD | -93.05% |
| 2006 Q2 | 0.03 USD | 4.67% |
| 2006 Q3 | 0.01 USD | -66.54% |
| 2006 Q4 | 0.00 USD | -57.78% |
| 2006 FY | - USD | -86.93% |
| 2005 Q2 | 0.06 USD | 446.06% |
| 2005 Q3 | 0.03 USD | -54.82% |
| 2005 Q4 | 0.37 USD | 1334.11% |
| 2005 Q1 | -0.02 USD | 96.89% |
| 2005 FY | - USD | 200.0% |
| 2004 Q3 | -0.01 USD | -117.33% |
| 2004 Q4 | -0.53 USD | -10092.31% |
| 2004 FY | - USD | -406.67% |
| 2004 Q1 | 0.05 USD | 30.86% |
| 2004 Q2 | 0.03 USD | -34.5% |
| 2003 Q1 | 0.03 USD | 113.12% |
| 2003 FY | - USD | 15.38% |
| 2003 Q4 | 0.04 USD | 2600.0% |
| 2003 Q3 | -0.00 USD | -101.57% |
| 2003 Q2 | 0.09 USD | 161.29% |
| 2002 FY | - USD | -27.78% |
| 2002 Q4 | 0.02 USD | -63.72% |
| 2002 Q3 | 0.04 USD | 11.36% |
| 2002 Q2 | 0.04 USD | -29.79% |
| 2002 Q1 | 0.06 USD | 34.29% |
| 2001 Q1 | 0.05 USD | 180.0% |
| 2001 FY | - USD | -14.29% |
| 2001 Q4 | 0.04 USD | -17.16% |
| 2001 Q3 | 0.05 USD | 28.03% |
| 2001 Q2 | 0.04 USD | -22.05% |
| 2000 Q2 | 0.02 USD | -70.49% |
| 2000 Q1 | 0.07 USD | -54.13% |
| 2000 FY | - USD | -46.15% |
| 2000 Q4 | -0.06 USD | -137.35% |
| 2000 Q3 | 0.17 USD | 737.44% |
| 1999 Q4 | 0.15 USD | 83.6% |
| 1999 Q2 | 0.09 USD | 20.99% |
| 1999 Q1 | 0.07 USD | 110.27% |
| 1999 FY | - USD | 156.52% |
| 1999 Q3 | 0.08 USD | -7.37% |
| 1998 FY | - USD | -400.0% |
| 1998 Q4 | -0.71 USD | -983.97% |
| 1998 Q2 | 0.01 USD | -94.46% |
| 1998 Q1 | 0.13 USD | 0.0% |
| 1998 Q3 | -0.07 USD | -1009.72% |
| 1997 Q3 | 0.01 USD | -75.56% |
| 1997 FY | - USD | -77.67% |
| 1997 Q2 | 0.06 USD | -61.27% |
| 1997 Q1 | 0.15 USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aurora Cannabis Inc. | -1.60 CAD | 46.875% |
| Avicanna Inc. | -0.09 CAD | -812.997% |
| Avant Brands Inc. | -0.61 CAD | -39.344% |
| Cardiol Therapeutics Inc. | -0.44 CAD | -93.182% |
| Crescita Therapeutics Inc. | -0.10 CAD | -767.347% |
| Knight Therapeutics Inc. | -0.16 CAD | -431.25% |
| MediPharm Labs Corp. | -0.04 CAD | -2261.111% |
| OrganiGram Holdings Inc. | -2.82 CAD | 69.858% |
| Canopy Growth Corporation | -8.79 CAD | 90.33% |
| Willow Biosciences Inc. | -0.10 CAD | -750.0% |
| Auxly Cannabis Group Inc. | -0.04 CAD | -1793.096% |